Pfizer (PFE) Tops Q3 EPS by 1c, Updates FY Guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $24.29 +2.62%
EPS Growth %: -12.8%
Financial Fact:
Cash dividends paid per common share (in dollars per share): 0.3
Today's EPS Names:
CGEH, NAKA, APOG, More
EPS Growth %: -12.8%
Financial Fact:
Cash dividends paid per common share (in dollars per share): 0.3
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q3 EPS of $0.72, $0.01 better than the analyst estimate of $0.71. Revenue for the quarter came in at $12.1 billion versus the consensus estimate of $12.33 billion.
GUIDANCE:
Pfizer sees FY2020 EPS of $2.88-$2.93, versus the consensus of $2.90. Pfizer sees FY2020 revenue of $48.8-49.5 billion, versus the consensus of $49.34 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
- KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
